39,970
Views
139
CrossRef citations to date
0
Altmetric
Reviews

How does high DHA fish oil affect health? A systematic review of evidence

, , , &

References

  • Abdukeyum, G. G., A. J. Owen, T. A. Larkin, and P. L. McLennan. 2016. Up-Regulation of Mitochondrial Antioxidant Superoxide Dismutase Underpins Persistent Cardiac Nutritional-Preconditioning by Long Chain n-3 Polyunsaturated Fatty Acids in the Rat. Journal of Clinical Medicine 5:32.
  • Abdukeyum, G. G., A. J. Owen, and P. L. McLennan. 2008. Dietary (n-3) long-chain polyunsaturated fatty acids inhibit ischemia and reperfusion arrhythmias and infarction in rat heart not enhanced by ischemic preconditioning. Journal of Nutrition 138:1902–09.
  • Adkins, Y., and D. S. Kelley. 2010. Mechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids. Journal of Nutritional Biochemistry 21:781–92.
  • Allaire, J., W. S. Harris, C. Vors, A. Charest, J. Marin, K. H. Jackson, A. Tchernof, P. Couture, and B. Lamarche. 2017. Supplementation with high-dose docosahexaenoic acid increases the Omega-3 Index more than high-dose eicosapentaenoic acid. Prostaglandins Leukotrienes and Essential Fatty Acids 120:8–14.
  • Anderton, B. H. 2002. Ageing of the brain. Mechanisms of Ageing and Development 123:811–7.
  • Andrieu, S., S. Guyonnet, N. Coley, C. Cantet, M. Bonnefoy, S. Bordes, L. Bories, M.-N. Cufi, T. Dantoine, J.-F. Dartigues, et al. 2017. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. Lancet Neurologia 16:377–389.
  • Arai, T., H-j. Kim, H. Chiba, and A. Matsumoto. 2009. Anti-obesity effect of fish oil and fish oil-fenofibrate combination in female KK mice. Journal of Atherosclerosis and Thrombosis 16:674–83.
  • Armah, C. K., K. G. Jackson, I. Doman, L. James, F. Cheghani, and A. M. Minihane. 2008. Fish oil fatty acids improve postprandial vascular reactivity in healthy men. Clinical Science (Lond.) 114:679–86.
  • Atwell, K., C. T. Collins, T. R. Sullivan, P. Ryan, R. A. Gibson, M. Makrides, and A. J. McPhee. 2013. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates. Journal of Paediatrics and Child Health H 49:E17–22.
  • Avramovic, N., V. Dragutinovic, D. Krstic, M. Colovic, A. Trbovic, S. de Luka, I. Milovanovic, and T. Popovic. 2012. The effects of omega 3 fatty acid supplementation on brain tissue oxidative status in aged wistar rats. Hippokratia 16:241–5.
  • Ayer, J. G., J. A. Harmer, W. Xuan, B. Toelle, K. Webb, C. Almqvist, G. B. Marks, and D. S. Celermajer. 2009. Dietary supplementation with n− 3 polyunsaturated fatty acids in early childhood: effects on blood pressure and arterial structure and function at age 8 y. American Journal of Clinical Nutrition 90:438–46.
  • Bakker, E. C., A. C. van Houwelingen, and G. Hornstra. 1999. Early nutrition, essential fatty acid status and visual acuity of term infants at 7 months of age. European Journal Clinical Nutrition 53:872–9.
  • Balk, E. M., A. H. Lichtenstein, M. Chung, B. Kupelnick, P. Chew, and J. Lau. 2006. Review: Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review. Atherosclerosis 189:19–30.
  • Ballantyne, C. M., H. E. Bays, J. J. Kastelein, E. Stein, J. L. Isaacsohn, R. A. Braeckman, and P. N. Soni. 2012. Efficacy and safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in statin-treated patients with persistent high triglycerides (from the ANCHOR study). American Journal of Cardiology 110:984–92.
  • Bang, H. O., J. Dyerberg, and A. B. Nielson. 1971. Plasma lipid and lipoprotein pattern in Greenlandic West-Coast Eskimos. Lancet 1:1143–&.
  • Barbadoro, P., I. Annino, E. Ponzio, R. M. L. Romanelli, M. M. D'Errico, E. Prospero, and A. Minelli. 2013. Fish oil supplementation reduces cortisol basal levels and perceived stress: A randomized, placebo-controlled trial in abstinent alcoholics. Molecular Nutrition & Food Research 57:1110–1114.
  • Bays, H. E., C. M. Ballantyne, J. J. Kastelein, J. L. Isaacsohn, R. A. Braeckman, and P. N. Soni. 2011. Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] trial). American Journal of Cardiology 108:682–90.
  • Bazan, N. G. 2013. The docosanoid neuroprotectin D1 induces homeostatic regulation of neuroinflammation and cell survival. Prostaglandins Leukotrienes and Essential Fatty Acids 88(1):127–129.
  • Best, K. P., T. Sullivan, D. Palmer, M. Gold, D. J. Kennedy, J. Martin, and M. Makrides. 2016. Prenatal fish oil supplementation and allergy: 6-Year follow-up of a randomized controlled trial. Pediatrics 137.
  • Birch, D. G., E. E. Birch, D. R. Hoffman, and R. D. Uauy. 1992. Retinal development in very-low-birth-weight infants fed diets differing in omega-3-fatty-acids. Investigative Ophthalmology & Visual Science 33:2365–76.
  • Birch, E. E., Y. S. Castaneda, D. H. Wheaton, D. G. Birch, R. D. Uauy, and D. R. Hoffman. 2005. Visual maturation of term infants fed long-chain polyunsaturated fatty acid-supplemented or control formula for 12 mo. American Journal of Clinical Nutrition 81:871–879.
  • Birch, E. E., D. R. Hoffman, R. Uauy, D. G. Birch, and C. Prestidge. 1998. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Pediatric Research 44:201–9.
  • Bradbury, J., S. P. Myers, and C. Oliver. 2004. An adaptogenic role for omega-3 fatty acids in stress; a randomised placebo controlled double blind intervention study (pilot)[ISRCTN22569553]. Nutrition Journal 3:20.
  • Brenna, J. T., and G. Y. Diau. 2007. The influence of dietary docosahexaenoic acid and arachidonic acid on central nervous system polyunsaturated fatty acid composition. Prostaglandins, Leukotrienes and Essential Fatty Acids 77:247–50.
  • Brew, B. K., B. G. Toelle, K. L. Webb, C. Almqvist, G. B. Marks, and C. investigators. 2015. Omega-3 supplementation during the first 5 years of life and later academic performance: a randomised controlled trial. European Journal of Clinical Nutrition 69:419–24.
  • Brochot, A., M. Guinot, D. Auchere, J.-P. Macaire, P. Weill, A. Grynberg, and D. Rousseau-Ralliard. 2009. Effects of alpha-linolenic acid vs. docosahexaenoic acid supply on the distribution of fatty acids among the rat cardiac subcellular membranes after a short-or long-term dietary exposure. Nutrition & Metabolism 6:14.
  • Brouwer, I. A., P. L. Zock, L. G. van Amelsvoort, M. B. Katan, and E. G. Schouten. 2002. Association between n-3 fatty acid status in blood and electrocardiographic predictors of arrhythmia risk in healthy volunteers. American Journal of Cardiology 89:629–31.
  • Buckley, J. D., S. Burgess, K. J. Murphy, and P. R. Howe. 2009. DHA-rich fish oil lowers heart rate during submaximal exercise in elite Australian Rules footballers. Journal of Science and Medicine in Sport 12:503–7.
  • Buckley, R., B. Shewring, R. Turner, P. Yaqoob, and A. M. Minihane. 2004. Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjects. British Journal of Nutrition 92:477–483.
  • Burdge, G. C., and P. C. Calder. 2005. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reproduction Nutrition Development 45:581–97.
  • Bush, R. A., A. Malnoe, C. E. Reme, and T. P. Williams. 1994. Dietary deficiency of N-3 fatty-acids alters rhodopsin content and function in the rat retina. Investigative Ophthalmology & Visual Science 35:91–100.
  • Cabello, I., O. Servitje, X. Corbella, I. Bardés, and X. Pintó. 2017. Omega‐3 fatty acids as adjunctive treatment for bexarotene‐induced hypertriglyceridaemia in patients with cutaneous T‐cell lymphoma. Clinical and Experimental Dermatology 42:276–81.
  • Campoy, C., M. V. Escolano-Margarit, R. Ramos, M. Parrilla-Roure, G. Csábi, J. Beyer, M. C. Ramirez-Tortosa, A. M. Molloy, T. Decsi, and B. V. Koletzko. 2011. Effects of prenatal fish-oil and 5-methyltetrahydrofolate supplementation on cognitive development of children at 6.5 y of age1–5. American Journal of Clinical Nutrition 94:1880S–8S.
  • Canugovi, C., M. Misiak, L. K. Ferrarelli, D. L. Croteau, and V. A. Bohr. 2013. The role of DNA repair in brain related disease pathology. DNA Repair 12:578–87.
  • Carlson, S. E., S. H. Werkman, P. G. Rhodes, and E. A. Tolley. 1993. Visual-acuity development in healthy preterm infants – effect of marine-oil supplementation. American Journal of Clinical Nutrition 58:35–42.
  • Carlson, S. E., S. H. Werkman, and E. A. Tolley. 1996. Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia. American Journal of Clinical Nutrition 63:687–97.
  • Caslake, M. J., E. A. Miles, B. M. Kofler, G. Lietz, P. Curtis, C. K. Armah, A. C. Kimber, J. P. Grew, L. Farrell, J. Stannard, et al. 2008. Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study. American Journal of Clinical Nutrition 88:618–29.
  • Castellano, C.-A., I. Audet, J.-P. Laforest, Y. Chouinard, and J. J. Matte. 2010. Fish oil diets do not improve insulin sensitivity and secretion in healthy adult male pigs. British Journal of Nutrition 103:189–96.
  • Castellano, C. A., I. Audet, J. P. Laforest, J. J. Matte, and M. Suh. 2011. Fish oil diets alter the phospholipid balance, fatty acid composition, and steroid hormone concentrations in testes of adult pigs. Theriogenology 76:1134–45.
  • Cheatham, C. L., A. S. Nerhammer, M. Asserhøj, K. F. Michaelsen, and L. Lauritzen. 2011. Fish oil supplementation during lactation: Effects on cognition and behavior at 7 years of age. Lipids 46:637–45.
  • Chen, C. T., Z. Liu, M. Ouellet, F. Calon, and R. P. Bazinet. 2009. Rapid beta-oxidation of eicosapentaenoic acid in mouse brain: an in situ study. Prostaglandins, Leukotrienes and Essential Fatty Acids 80:157–63.
  • Chong, M. F.-F., S. Lockyer, C. J. Saunders, and J. A. Lovegrove. 2010. Long chain n− 3 PUFA-rich meal reduced postprandial measures of arterial stiffness. Clinical Nutrition 29:678–81.
  • Clayton, E. H., T. L. Hanstock, S. J. Hirneth, C. J. Kable, M. L. Garg, and P. L. Hazell. 2009. Reduced mania and depression in juvenile bipolar disorder associated with long-chain omega-3 polyunsaturated fatty acid supplementation. European Journal of Clinical Nutrition 63:1037–40.
  • Clouard, C., A. S. Souza, W. J. J. Gerrits, R. Hovenier, A. Lammers, and J. E. Bolhuis. 2015. Maternal fish oil supplementation affects the social behavior, brain fatty acid profile, and sickness response of piglets. Journal of Nutrition 145:2176–84.
  • Collins, C. T., M. Makrides, R. A. Gibson, A. J. McPhee, P. G. Davis, L. W. Doyle, K. Simmer, P. B. Colditz, S. Morris, and T. R. Sullivan. 2011. Pre-and post-term growth in pre-term infants supplemented with higher-dose DHA: a randomised controlled trial. British Journal of Nutrition 105:1635–43.
  • Conquer, J. A., and B. J. Holub. 1996. Supplementation with an algae source of docosahexaenoic acid increases (n-3) fatty acid status and alters selected risk factors for heart disease in vegetarian subjects. Journal of Nutrition 126:3032–39.
  • Corder, K. E., K. R. Newsham, J. L. McDaniel, U. R. Ezekiel, and E. P. Weiss. 2016. Effects of short-term docosahexaenoic acid supplementation on markers of inflammation after eccentric strength exercise in women. Journal of Sports Science and Medicine 15:176.
  • Cottin, S. C., T. A. Sanders, and W. L. Hall. 2011. The differential effects of EPA and DHA on cardiovascular risk factors. Proceedings of the Nutrition Society 70:215–31.
  • Crawford, M. A., R. P. Bazinet, and A. J. Sinclair. 2009. Fat intake and CNS functioning: ageing and disease. Annals of Nutrition and Metabolism 55:202–28.
  • Crawford, M. A., C. L. Broadhurst, M. Guest, A. Nagar, Y. Wang, K. Ghebremeskel, and W. F. Schmidt. 2013. A quantum theory for the irreplaceable role of docosahexaenoic acid in neural cell signalling throughout evolution. Prostaglandins, Leukotrienes and Essential Fatty Acids 88(1):5–13.
  • Crawford, M. A., N. M. Casperd, and A. J. Sinclair. 1976. The long chain metabolites of linoleic avid linolenic acids in liver and brain in herbivores and carnivores. Comparative Biochemistry and Physiology B 54:395–401.
  • Crowe, F. L., C. Murray Skeaff, T. J. Green, and A. R. Gray. 2008. Serum n-3 long-chain PUFA differ by sex and age in a population-based survey of New Zealand adolescents and adults. British Journal of Nutrition 99:168–74.
  • Cussons, A. J., G. F. Watts, T. A. Mori, and B. G. Stuckey. 2009. Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy. The Journal of Clinical Endocrinology and Metabolism 94:3842–48.
  • D'Vaz, N., S. Meldrum, J. Dunstan, T. Lee‐Pullen, J. Metcalfe, B. Holt, M. Serralha, M. Tulic, T. Mori, and S. Prescott. 2012. Fish oil supplementation in early infancy modulates developing infant immune responses. Clinical & Experimental Allergy 42:1206–16.
  • Dallongeville, J., J. Yarnell, P. Ducimetière, D. Arveiler, J. Ferrières, M. Montaye, G. Luc, A. Evans, A. Bingham, B. Hass, et al. 2003. Fish Consumption Is Associated With Lower Heart Rates. Circulation 108:820–25.
  • Damsgaard, C. T., C. Mølgaard, J. Matthiessen, S. N. Gyldenløve, and L. Lauritzen. 2012. The effects of n-3 long-chain polyunsaturated fatty acids on bone formation and growth factors in adolescent boys. Pediatric Research 71:713–9.
  • Dangour, A. D., E. Allen, D. Elbourne, N. Fasey, A. E. Fletcher, P. Hardy, G. E. Holder, R. Knight, L. Letley, M. Richards, et al. 2010. Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: A randomized, double-blind, controlled trial. American Journal of Clinical Nutrition 91:1725–1732.
  • Davis, D. J., P. M. Hecht, E. Jasarevic, D. Q. Beversdorf, M. J. Will, K. Fritsche, and C. H. Gillespie. 2017. Sex-specific effects of docosahexaenoic acid (DHA) on the microbiome and behavior of socially-isolated mice. Brain, Behavior, and Immunity 59:38–48.
  • Dawson, K., L. Zhao, Y. Adkins, M. Vemuri, R. L. Rodriguez, J. P. Gregg, D. S. Kelley, and D. H. Hwang. 2012. Modulation of blood cell gene expression by DHA supplementation in hypertriglyceridemic men. Journal of Nutritional Biochemistry 23:616–21.
  • DeFina, L. F., L. G. Marcoux, S. M. Devers, J. P. Cleaver, and B. L. Willis. 2010. Effects of omega-3 supplementation in combination with diet and exercise on weight loss and body composition. American Journal of Clinical Nutrition 93:455–62.
  • Delgado-Noguera, M. F., J. A. Calvache, X. B. Cosp, E. P. Kotanidou, and A. Galli-Tsinopoulou. 2015. Supplementation with long chain polyunsaturated fatty acids (LCPUFA) to breastfeeding mothers for improving child growth and development. The Cochrane Database of Systematic Reviews.
  • DeMar, J. C., H. J. Lee, K. Z. Ma, L. Chang, J. M. Bell, S. I. Rapoport, and R. P. Bazinet. 2006. Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats. Biochimica et Biophysica Acta 1761:1050–59.
  • DiLorenzo, F. M., C. J. Drager, and J. W. Rankin. 2014. Docosahexaenoic acid affects markers of inflammation and muscle damage after eccentric exercise. The Journal of Strength & Conditioning Research 28:2768–74.
  • Din, J. N., S. A. Harding, C. J. Valerio, J. Sarma, K. Lyall, R. A. Riemersma, D. E. Newby, and A. D. Flapan. 2008. Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in man. Atherosclerosis 197:290–6.
  • Du, C. Y., Y. Fujii, M. Ito, M. Harada, E. Moriyama, R. Shimada, A. Ikemoto, and H. Okuyama. 2004. Dietary polyunsaturated fatty acids suppress acute hepatitis, alter gene expression and prolong survival of female Long-Evans Cinnamon rats, a model of Wilson disease. Journal of Nutritional Biochemistry 15:273–80.
  • Du, S., J. Jin, W. Fang, and Q. Su. 2015. Does fish oil have an anti-obesity effect in overweight/obese adults? A Meta-Analysis of Randomized Controlled Trials. PLoS One 10:e0142652.
  • Dunstan, J. A., K. Simmer, G. Dixon, and S. L. Prescott. 2008. Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Archives of Disease in Childhood. Fetal and Neonatal Edition 93:F45–50.
  • Dyall, S. C. 2015. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Frontiers in Aging Neuroscience 7:52.
  • Dyerberg, J., H. O. Bang, E. Stoffersen, S. Moncada, and J. R. Vane. 1978. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 2:117–9.
  • EFSA Panel on Dietetic Products Nutrition Allergies. 2010. Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA Journal 8.
  • Egert, S., M. Fobker, G. Andersen, V. Somoza, H. F. Erbersdobler, and U. Wahrburg. 2008. Effects of dietary α-linolenic acid, eicosapentaenoic acid or docosahexaenoic acid on parameters of glucose metabolism in healthy volunteers. Annals of Nutrition and Metabolism 53:182–7.
  • Engstrm, K., A. S. Saldeen, B. Yang, J. L. Mehta, and T. Saldeen. 2009. Effect of fish oils containing different amounts of EPA, DHA, and antioxidants on plasma and brain fatty acids and brain nitric oxide synthase activity in rats. Upsala Journal of Medical Sciences 114:206–13.
  • Escolano-Margarit, M. V., R. Ramos, J. Beyer, G. Csabi, M. Parrilla-Roure, F. Cruz, M. Perez-Garcia, M. Hadders-Algra, A. Gil, T. Decsi, et al. 2011. Prenatal DHA status and neurological outcome in children at age 5.5 years are positively associated. Journal of Nutrition 141:1216–23.
  • Faldella, G., M. Govoni, R. Alessandroni, E. Marchiani, G. P. Salvioli, P. L. Biagi, and C. Spano. 1996. Visual evoked potentials and dietary long chain polyunsaturated fatty acids in preterm infants. Archives of Disease in Childhood 75:F108–12.
  • FAO/WHO. 2008. Interim Summary of Conclusions and Dietary Recommendations on Total Fat & Fatty Acids. The joint FAO/WHO expert consultation on fats & fatty acids in human nutrition, November 10–14, 2008. Geneva, Switzerland: WHO HQ.
  • Fernandes, J. S., M. A. Mori, R. Ekuni, R. M. W. Oliveira, and H. Milani. 2008. Long-term treatment with fish oil prevents memory impairments but not hippocampal damage in rats subjected to transient, global cerebral ischemia. Nutrition Research 28:798–808.
  • Finnegan, Y. E., A. M. Minihane, E. C. Leigh-Firbank, S. Kew, G. W. Meijer, R. Muggli, P. C. Calder, and C. M. Williams. 2003. Plant-and marine-derived n− 3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. American Journal of Clinical Nutrition 77:783–95.
  • Flock, M. R., A. C. Skulas-Ray, W. S. Harris, T. D. Etherton, J. A. Fleming, and P. M. Kris-Etherton. 2013. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose–response randomized controlled trial. Journal of the American Heart Association 2:e000513.
  • Food and Agriculture Organization of the United Nations. 2010. Fats and fatty acids in human nutrition. Report of an expert consultation. FAO Food and Nutrition Paper 91:1–166.
  • Frangou, S., M. Lewis, J. WoUard, and A. Simmons. 2007. Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder. Journal of Psychopharmacology 21:435–9.
  • Freund-Levi, Y., H. Basun, T. Cederholm, G. Faxen-Irving, A. Garlind, M. Grut, I. Vedin, J. Palmblad, L. O. Wahlund, and M. Eriksdotter-Jonhagen. 2008. Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms. International Journal of Geriatric Psychiatry 23:161–9.
  • Freund-Levi, Y., I. Vedin, E. Hjorth, H. Basun, G. Faxén Irving, M. Schultzberg, M. Eriksdotter, J. Palmblad, B. Vessby, L. O. Wahlund, et al. 2014. Effects of supplementation with omega-3 fatty acids on oxidative stress and inflammation in patients with Alzheimer's disease: The OmegAD study. Journal of Alzheimer's Disease 42:823–31.
  • Ghasemifard, S., K. Hermon, G. M. Turchini, and A. J. Sinclair. 2015a. Metabolic fate (absorption, β-oxidation and deposition) of long-chain n-3 fatty acids is affected by sex and by the oil source (krill oil or fish oil) in the rat. British Journal of Nutrition 114:684–92.
  • Ghasemifard, S., A. J. Sinclair, G. Kaur, P. Lewandowski, and G. M. Turchini. 2015b. What is the most effective way of increasing the bioavailability of dietary long chain omega-3 fatty acids – daily vs. weekly administration of fish oil? Nutrients 7:5628–45.
  • Ghasemifard, S., G. M. Turchini, and A. J. Sinclair. 2014. Omega-3 long chain fatty acid “bioavailability”: a review of evidence and methodological considerations. Progress in Lipid Research 56:92–108.
  • Gorjão, R., R. Verlengia, T.Md. Lima, F. G. Soriano, M. F. C. Boaventura, C. C. Kanunfre, C. M. Peres, S. C. Sampaio, R. Otton, A. Folador, et al. 2006. Effect of docosahexaenoic acid-rich fish oil supplementation on human leukocyte function. Clinical Nutrition 25:923–38.
  • Gould, J. F., L. G. Smithers, and M. Makrides. 2013. The effect of maternal omega-3 (n-3) LCPUFA supplementation during pregnancy on early childhood cognitive and visual development: a systematic review and meta-analysis of randomized controlled trials. American Journal of Clinical Nutrition 97:531–44.
  • Grenyer, B. F., T. Crowe, B. Meyer, A. J. Owen, E. M. Grigonis-Deane, P. Caputi, and P. R. Howe. 2007. Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial. Progress in Neuro-Psychopharmacology & Biological Psychiatry 31:1393–96.
  • Grimsgaard, S., K. H. Bønaa, J.-B. Hansen, and E. Myhre. 1998. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. American Journal of Clinical Nutrition 68:52–59.
  • Gunnarsdottir, I., H. Tomasson, M. Kiely, J. Martinez, N. Bandarra, M. Morais, and I. Thorsdottir. 2008. Inclusion of fish or fish oil in weight-loss diets for young adults: effects on blood lipids. International Journal of Obesity 32:1105–12.
  • Guzmán, J. F., H. Esteve, C. Pablos, A. Pablos, C. Blasco, and J. A. Villegas. 2011. DHA-rich fish oil improves complex reaction time in female elite soccer players. Journal of Sports Science and Medicine 10:301.
  • Halade, G. V., M. M. Rahman, A. Bhattacharya, J. L. Barnes, B. Chandrasekar, and G. Fernandes. 2010. Docosahexaenoic acid-enriched fish oil attenuates kidney disease and prolongs median and maximal life span of autoimmune lupus-prone mice. Journal of Immunology 184:5280–86.
  • Hamazaki, K., D. Syafruddin, I. S. Tunru, M. F. Azwir, P. B. Asih, S. Sawazaki, and T. Harnazaki. 2008. The effects of docosahexaenoic acid-rich fish oil on behavior, school attendance rate and malaria infection in school children – a double-blind, randomized, placebo-controlled trial in Lampung, Indonesia. Asia Pacific Journal of Clinical Nutrition 17:258–63.
  • Hansell, A. L., N. Rose, C. T. Cowie, E. G. Belousova, I. Bakolis, K. Ng, B. G. Toelle, and G. B. Marks. 2014. Weighted road density and allergic disease in children at high risk of developing asthma. PLoS One 9:e98978–e98978.
  • Harris, W. S. 1997. n-3 fatty acids and serum lipoproteins: human studies. American Journal of Clinical Nutrition 65:1645S–1654S.
  • Harris, W. S., S. A. Sands, S. L. Windsor, H. A. Ali, T. L. Stevens, A. Magalski, C. B. Porter, and A. M. Borkon. 2004. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients correlation with erythrocytes and response to supplementation. Circulation 110:1645–9.
  • Harris, W. S., and C. Von Schacky. 2004. The Omega-3 Index: a new risk factor for death from coronary heart disease? Preventive Medicine 39:212–0.
  • Hashimoto, M., S. Hossain, H. Yamasaki, K. Yazawa, and S. Masumura. 1999. Effects of eicosapentaenoic acid and docosahexaenoic acid on plasma membrane fluidity of aortic endothelial cells. Lipids 34:1297–304.
  • Haugaard, S. B., S. Madsbad, C. E. Høy, and A. Vaag. 2006. Dietary intervention increases n‐3 long‐chain polyunsaturated fatty acids in skeletal muscle membrane phospholipids of obese subjects. Implications for insulin sensitivity. Clinical Endocrinology 64:169–78.
  • Helland, I. B., O. D. Saugstad, L. Smith, K. Saarem, K. Solvoll, T. Ganes, and C. A. Drevon. 2001. Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics 108:E82.
  • Helland, I. B., L. Smith, B. Blomen, K. Saarem, O. D. Saugstad, and C. A. Drevon. 2008. Effect of supplementing pregnant and lactating mothers with n-3 very-long-chain fatty acids on children's IQ and body mass index at 7 years of age. Pediatrics 122:E472–9.
  • Helland, I. B., L. Smith, K. Saarem, O. D. Saugstad, and C. A. Drevon. 2003. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 111.
  • Henry, R., G. E. Peoples, and P. L. McLennan. 2015. Muscle fatigue resistance in the rat hindlimb in vivo from low dietary intakes of tuna fish oil that selectively increase phospholipid n-3 docosahexaenoic acid according to muscle fibre type. British Journal of Nutrition 114:873–84.
  • Higuchi, T., N. Shirai, and H. Suzuki. 2006. Reduction in plasma glucose after lipid changes in mice fed fish oil, docosahexaenoic acid, and eicosapentaenoic acid diets. Annals of Nutrition and Metabolism 50:147–54.
  • Hill, A. M., J. D. Buckley, K. J. Murphy, and P. R. Howe. 2007a. Combining fish-oil supplements with regular aerobic exercise improves body composition and cardiovascular disease risk factors. American Journal of Clinical Nutrition 85:1267–74.
  • Hill, A. M., C. Worthley, K. J. Murphy, J. D. Buckley, A. Ferrante, and P. R. Howe. 2007b. n-3 Fatty acid supplementation and regular moderate exercise: differential effects of a combined intervention on neutrophil function. British Journal of Nutrition 98:300–9.
  • Hirayama, S., T. Hamazaki, and K. Terasawa. 2004. Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder – A placebo-controlled double-blind study. European Journal of Clinical Nutrition 58:467–73.
  • Hoffman, D. R., E. E. Birch, Y. S. Castaneda, S. L. Fawcett, D. H. Wheaton, D. G. Birch, and R. Uauy. 2003. Visual function in breast-fed term infants weaned to formula with or without long-chain polyunsaturates at 4 to 6 months: A randomized clinical trial. The Journal of Pediatrics 142:669–677.
  • Holguin, F., M. M. Téllez-Rojo, M. Lazo, D. Mannino, J. Schwartz, M. Hernández, and I. Romieu. 2005. Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest 127:1102–07.
  • Horrocks, L. A., and Y. K. Yeo. 1999. Health benefits of docosahexaenoic acid (DHA). Pharmacological Research 40:211–25.
  • Huggins, C. E., C. L. Curl, R. Patel, P. L. McLennan, M. L. Theiss, T. Pedrazzini, S. Pepe, and L. M. Delbridge. 2009. Dietary fish oil is antihypertrophic but does not enhance postischemic myocardial function in female mice. American Journal of Physiology-Heart and Circulatory Physiology 296:H957–66.
  • Hurtado, J. A., C. Iznaola, M. Pena, J. Ruiz, L. Pena-Quintana, N. Kajarabille, Y. Rodriguez-Santana, P. Sanjurjo, L. Aldamiz-Echevarria, J. Ochoa, et al. 2015. Effects of maternal omega-3 supplementation on fatty acids and on visual and cognitive development. Journal of Pediatric Gastroenterology and Nutrition 61:472–80.
  • Innis, S. M. 2005. Essential fatty acid transfer and fetal development. Placenta 26:S70–5.
  • Itomura, M., K. Hamazaki, S. Sawazaki, M. Kobayashi, K. Terasawa, S. Watanabe, and T. Hamazaki. 2005. The effect of fish oil on physical aggression in schoolchildren – a randomized, double-blind, placebo-controlled trial. Journal of Nutritional Biochemistry 16:163–71.
  • Jackson, P. A., M. E. Deary, J. L. Reay, A. B. Scholey, and D. O. Kennedy. 2012a. No effect of 12 weeks' supplementation with 1 g DHA-rich or EPA-rich fish oil on cognitive function or mood in healthy young adults aged 18–35 years. British Journal of Nutrition 107:1232–43.
  • Jackson, P. A., J. S. Forster, J. G. Bell, J. R. Dick, I. Younger, and D. O. Kennedy. 2016. DHA supplementation alone or in combination with other nutrients does not modulate cerebral hemodynamics or cognitive function in healthy older adults. Nutrients 8:86.
  • Jackson, P. A., J. L. Reay, A. B. Scholey, and D. O. Kennedy. 2012b. DHA-rich oil modulates the cerebral haemodynamic response to cognitive tasks in healthy young adults: a near IR spectroscopy pilot study. British Journal of Nutrition 107:1093–98.
  • Jackson, P. A., J. L. Reay, A. B. Scholey, and D. O. Kennedy. 2012c. Docosahexaenoic acid-rich fish oil modulates the cerebral hemodynamic response to cognitive tasks in healthy young adults. Biological Psychology 89:183–90.
  • Jacobson, T. A., S. B. Glickstein, J. D. Rowe, and P. N. Soni. 2012. Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review. Journal of Clinical Lipidology 6:5–18.
  • James, M. J., T. R. Sullivan, R. G. Metcalf, and L. G. Cleland. 2014. Pitfalls in the use of randomised controlled trials for fish oil studies with cardiac patients. British Journal of Nutrition 112:812–20.
  • Johnson, E. J., K. Mcdonald, S. M. Caldarella, H-y. Chung, A. M. Troen, and D. M. Snodderly. 2008. Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. Nutritional Neuroscience 11:75–83.
  • Kew, S., T. Banerjee, A. M. Minihane, Y. E. Finnegan, R. Muggli, R. Albers, C. M. Williams, and P. C. Calder. 2003. Lack of effect of foods enriched with plant- or marine-derived n-3 fatty acids on human immune function. American Journal of Clinical Nutrition 77:1287–95.
  • Kew, S., M. D. Mesa, S. Tricon, R. Bitckley, A. M. Minihane, and P. Yaqoob. 2004. Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans. American Journal of Clinical Nutrition 79:674–81.
  • Khan, F., K. Elherik, C. Bolton-Smith, R. Barr, A. Hill, I. Murrie, and J. J. Belch. 2003. The effects of dietary fatty acid supplementation on endothelial function and vascular tone in healthy subjects. Cardiovascular Research 59:955–62.
  • Kohno, H., N. Yamaguchi, C. Ohdoi, S. Nakajima, S. Odashima, and T. Tanaka. 2000. Modifying effect of tuna orbital oil rich in docosahexaenoic acid and vitamin D-3 on azoxymethane-induced colonic aberrant crypt foci in rats. Oncology Reports 7:1069–74.
  • Koletzko, B., E. Lien, C. Agostoni, H. Bohles, C. Campoy, I. Cetin, T. Decsi, J. W. Dudenhausen, C. Dupont, S. Forsyth, et al. 2008. The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. Journal of Perinatal Medicine 36:5–14.
  • Kook, K., B. H. Choi, S. S. Sun, F. Garcia, and K. H. Myung. 2002. Effect of fish oil supplement on growth performance, ruminal metabolism and fatty acid composition of longissimus muscle in Korean cattle. Asian-Australasian Journal of Animal Sciences 15:66–71.
  • Krebs, J., L. Browning, N. McLean, J. Rothwell, G. Mishra, C. Moore, and S. Jebb. 2006. Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women. International Journal of Obesity 30:1535–44.
  • Kris-Etherton, P. M., W. S. Harris, L. J. Appel, and American Heart Association. Nutrition, C. 2002. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106:2747–57.
  • Kumar, S., F. Sutherland, A. W. Teh, P. M. Heck, G. Lee, M. L. Garg, and P. B. Sparks. 2011. Effects of chronic omega-3 polyunsaturated fatty acid supplementation on human pulmonary vein and left atrial electrophysiology in paroxysmal atrial fibrillation. American Journal of Cardiology 108:531–5.
  • Kunesova, M., R. Braunerova, P. Hlavatý, and E. Tvrzicka. 2006. The influence of n-3 polyunsaturated fatty acids and very low calorie diet during a short-term weight reducing regimen on weight loss and serum fatty acid composition in severely obese women. Physiological Research 55:63.
  • Lagarde, M., M. Hachem, M. Picq, M. Guichardant, and N. Bernoud-Hubac. 2016. AceDoPC, a structured phospholipid to target the brain with docosahexaenoic acid. OCL 23:D102.
  • Larter, C. Z., M. M. Yeh, J. Cheng, J. Williams, S. Brown, A. Dela Pena, K. S. Bell‐Anderson, and G. C. Farrell. 2008. Activation of peroxisome proliferator‐activated receptor α by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation. European Journal of Gastroenterology & Hepatology 23:267–75.
  • Lauritzen, L., M. H. Jørgensen, T. B. Mikkelsen, I. M. Skovgaard, E.-M. Straarup, S. F. Olsen, C.-E. Høy, and K. F. Michaelsen. 2004. Maternal fish oil supplementation in lactation: effect on visual acuity and n− 3 fatty acid content of infant erythrocytes. Lipids 39:195–206.
  • Lauritzen, L., M. H. Jorgensen, S. F. Olsen, E. M. Straarup, and K. F. Michaelsen. 2005. Maternal fish oil supplementation in lactation: effect on developmental outcome in breast-fed infants. Reproduction Nutrition Development 45:535–47.
  • LeBlanc, C. J., D. W. Horohov, J. E. Bauer, G. Hosgood, and G. E. Mauldin. 2008. Effects of dietary supplementation with fish oil on in vivo production of inflammatory mediators in clinically normal dogs. American Journal of Veterinary Research 69:486–93.
  • Lee, L. K., S. Shahar, A. V. Chin, and N. A. M. Yusoff. 2013. Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): A 12-month randomised, double-blind, placebo-controlled trial. Psychopharmacology 225:605–12.
  • Li, K., T. Huang, J. Zheng, K. Wu, and D. Li. 2014. Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factor α: a meta-analysis. PLoS One 9:e88103–e88103.
  • Macartney, M. J., L. Hingley, M. A. Brown, G. E. Peoples, and P. L. McLennan. 2014. Intrinsic heart rate recovery after dynamic exercise is improved with an increased omega-3 index in healthy males. British Journal of Nutrition 112:1984–92.
  • Makrides, M., R. A. Gibson, A. J. McPhee, C. T. Collins, P. G. Davis, L. W. Doyle, K. Simmer, P. B. Colditz, S. Morris, L. G. Smithers, et al. 2009. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. JAMA 301:175–182.
  • Makrides, M., R. A. Gibson, A. J. McPhee, L. Yelland, J. Quinlivan, P. Ryan, L. W. Doyle, P. Anderson, P. L. Else, B. J. Meyer, et al. 2010. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: A randomized controlled trial. JAMA 304:1675–83.
  • Makrides, M., M. A. Neumann, B. Jeffrey, E. L. Lien, and R. A. Gibson. 2000. A randomized trial of different ratios of linoleic to alpha-linolenic acid in the diet of term infants: effects on visual function and growth. American Journal of Clinical Nutrition 71:120–9.
  • Manley, B. J., M. Makrides, C. T. Collins, A. J. McPhee, R. A. Gibson, P. Ryan, T. R. Sullivan, P. G. Davis, and C. Dino Steering. 2011. High-dose docosahexaenoic acid supplementation of preterm infants: Respiratory and allergy outcomes. Pediatrics 128:E71–7.
  • Mann, N. J., S. L. O'Connell, K. M. Baldwin, I. Singh, and B. J. Meyer. 2010. Effects of seal oil and tuna-fish oil on platelet parameters and plasma lipid levels in healthy subjects. Lipids 45:669–81.
  • Mansoori, A., G. Sotoudeh, M. Djalali, M.-R. Eshraghian, M. Keramatipour, E. Nasli-Esfahani, F. Shidfar, E. Alvandi, O. Toupchian, and F. Koohdani. 2016. Docosahexaenoic acid-rich fish oil supplementation improves body composition without influence of the PPARγ Pro12Ala polymorphism in patients with type 2 diabetes: A Randomized, double-blind, placebo-controlled clinical trial. Journal of Nutrigenetics and Nutrigenomics 8:195–204.
  • Marks, G. B., S. Mihrshahi, A. S. Kemp, E. R. Tovey, K. Webb, C. Almqvist, R. D. Ampon, D. Crisafulli, E. G. Belousova, C. M. Mellis, et al. 2006. Asthma diagnosis and treatment: Prevention of asthma during the first 5 years of life: A randomized controlled trial. The Journal of Allergy and Clinical Immunology 118:53–61.
  • Marques, C. G., V. C. Santos, A. C. Levada-Pires, T. M. Jacintho, R. Gorjao, T. C. Pithon-Curi, and M. F. Cury-Boaventura. 2015. Effects of DHA-rich fish oil supplementation on the lipid profile, markers of muscle damage, and neutrophil function in wheelchair basketball athletes before and after acute exercise. Applied Physiology, Nutrition, and Metabolism 40:596–604.
  • Martins, J. G. 2009. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. The Journal of the American College of Nutrition 28:525–42.
  • McEwen, B. J., M.-C. Morel-Kopp, W. Chen, G. H. Tofler, and C. M. Ward. 2013. Effects of omega-3 polyunsaturated fatty acids on platelet function in healthy subjects and subjects with cardiovascular disease. Seminars in Thrombosis and Hemostasis 39:25–32.
  • McEwen, B. J., M.-C. Morel-Kopp, G. H. Tofler, and C. M. Ward. 2015. The effect of omega-3 polyunsaturated fatty acids on fibrin and thrombin generation in healthy subjects and subjects with cardiovascular disease. Seminars in Thrombosis and Hemostasis 41:315–22.
  • McLennan, P. L. 2014. Cardiac physiology and clinical efficacy of dietary fish oil clarified through cellular mechanisms of omega-3 polyunsaturated fatty acids. European Journal of Applied Physiology 114:1333–56.
  • McLennan, P. L., and M. Y. Abeywardena. 2005. Membrane basis for fish oil effects on the heart: linking natural hibernators to prevention of human sudden cardiac death. The Journal of Membrane Biology 206:85–102.
  • McLennan, P., P. Howe, M. Abeywardena, R. Muggli, D. Raederstorff, M. Mano, T. Rayner, and R. Head. 1996. The cardiovascular protective role of docosahexaenoic acid. European Journal of Pharmacology 300:83–9.
  • McManus, S., N. Tejera, K. Awwad, D. Vauzour, N. Rigby, I. Fleming, A. Cassidy, and A. M. Minihane. 2016. Differential effects of EPA versus DHA on postprandial vascular function and the plasma oxylipin profile in men. Journal of Lipid Research 57:1720–27.
  • Meldrum, S., J. A. Dunstan, J. K. Foster, K. Simmer, and S. L. Prescott. 2015. Maternal fish oil supplementation in pregnancy: a 12 year follow-up of a randomised controlled trial. Nutrients 7:2061–67.
  • Meldrum, S. J., N. D'Vaz, K. Simmer, J. A. Dunstan, K. Hird, and S. L. Prescott. 2012. Effects of high-dose fish oil supplementation during early infancy on neurodevelopment and language: a randomised controlled trial. British Journal of Nutrition 108:1443–54.
  • Metcalf, R. G., M. J. James, R. A. Gibson, J. R. Edwards, J. Stubberfield, R. Stuklis, K. Roberts-Thomson, G. D. Young, and L. G. Cleland. 2007. Effects of fish-oil supplementation on myocardial fatty acids in humans. American Journal of Clinical Nutrition 85:1222–28.
  • Meyer, B. J., and R. H. de Groot. 2017. Effects of omega-3 long chain polyunsaturated fatty acid supplementation on cardiovascular mortality: the importance of the dose of DHA. Nutrients 9:1305.
  • Meyer, B. J., T. Hammervold, A. C. Rustan, and P. R. Howe. 2007. Dose-dependent effects of docosahexaenoic acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects. Lipids 42:109–15.
  • Meyer, B. J., A. Lane, and N. Mann. 2009. Comparison of seal oil to tuna oil on plasma lipid levels and blood pressure in hypertriglyceridaemic subjects. Lipids 44:827–35.
  • Micallef, M. A., and M. L. Garg. 2009. Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals. Atherosclerosis 204:476–82.
  • Miller, M. R., P. D. Nichols, and C. G. Carter. 2011. New Alternative n-3 Long-Chain Polyunsaturated Fatty Acid-Rich Oil Sources. In: Fish oil Replacement and Alternative Lipid Sources in Aquaculture Feeds, G. M. Turchini, W. K. Ng and D. R. Tocher, Eds., 325–50. CRC Press, Boca Raton, FL.
  • Milte, C. M., A. M. Coates, J. D. Buckley, A. M. Hill, and P. R. Howe. 2008. Dose-dependent effects of docosahexaenoic acid-rich fish oil on erythrocyte docosahexaenoic acid and blood lipid levels. British Journal of Nutrition 99:1083–88.
  • Molinar-Toribio, E., J. Pérez-Jiménez, S. Ramos-Romero, M. Romeu, M. Giralt, N. Taltavull, M. Munoz-Cortes, O. Jáuregui, L. Méndez, and I. Medina. 2015. Effect of n-3 PUFA supplementation at different EPA: DHA ratios on the spontaneously hypertensive obese rat model of the metabolic syndrome. British Journal of Nutrition 113:878–87.
  • Mori, T. A., V. Burke, I. B. Puddey, G. F. Watts, D. N. O'Neal, J. D. Best, and L. J. Beilin. 2000. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. American Journal of Clinical Nutrition 71:1085–94.
  • Mori, T. A., and R. J. Woodman. 2006. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Current Opinion in Clinical Nutrition & Metabolic Care 9:95–104.
  • Mozaffarian, D., A. Geelen, I. A. Brouwer, J. M. Geleijnse, P. L. Zock, and M. B. Katan. 2005. Effect of fish oil on heart rate in humans. Circulation 112:1945–52.
  • Mozaffarian, D., R. J. Prineas, P. K. Stein, and D. S. Siscovick. 2006. Dietary fish and n-3 fatty acid intake and cardiac electrocardiographic parameters in humans. Journal of the American College of Cardiology 48:478–84.
  • Mozaffarian, D., and J. H. Wu. 2011. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. Journal of the American College of Cardiology 58:2047–67.
  • Mozaffarian, D., and J. H. Wu. 2012. (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary? Journal of Nutrition 142:614S–625S.
  • Mozurkewich, E. L., C. M. Clinton, J. L. Chilimigras, S. E. Hamilton, L. J. Allbaugh, D. R. Berman, S. M. Marcus, V. C. Romero, M. C. Treadwell, K. L. Keeton, et al. 2013. The Mothers, Omega-3, and Mental Health Study: a double-blind, randomized controlled trial. American Journal of Obstetrics and Gynecology 208.
  • Muhlhausler, B. S., L. N. Yelland, R. McDermott, L. Tapsell, A. McPhee, R. A. Gibson, and M. Makrides. 2016. DHA supplementation during pregnancy does not reduce BMI or body fat mass in children: follow-up of the DHA to Optimize Mother Infant Outcome randomized controlled trial. American Journal of Clinical Nutrition 103:1489–96.
  • Munro, I. A., and M. L. Garg. 2012. Dietary supplementation with n-3 PUFA does not promote weight loss when combined with a very-low-energy diet. British Journal of Nutrition 108:1466–74.
  • Munro, I. A., and M. L. Garg. 2013a. Dietary supplementation with long chain omega-3 polyunsaturated fatty acids and weight loss in obese adults. Obesity Research & Clinical Practice 7:e173–81.
  • Munro, I. A., and M. L. Garg. 2013b. Prior supplementation with long chain omega-3 polyunsaturated fatty acids promotes weight loss in obese adults: a double-blinded randomised controlled trial. Food & Function 4:650–8.
  • Nelson, G., P. Schmidt, G. Bartolini, D. Kelley, and D. Kyle. 1997. The effect of dietary docosahexaenoic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans. Lipids 32:1129–36.
  • Neu, J., and R. A. Polin. 2012. Gastroenterology and nutrition: neonatology questions and controversies. 2nd ed., Saunders, Philadelphia, PA.
  • Neuringer, M., W. E. Connor, D. S. Lin, L. Barstad, and S. Luck. 1986. Biochemical and functional-effects of prenatal and postnatal omega-3-fatty-acid deficiency on retina and brain in rhesus-monkeys. Proceedings of the National Academy of Sciences of the United States of America 83:4021–5.
  • Newens, K. J., A. K. Thompson, K. G. Jackson, J. Wright, and C. M. Williams. 2011. DHA-rich fish oil reverses the detrimental effects of saturated fatty acids on postprandial vascular reactivity. American Journal of Clinical Nutrition 94:742–8.
  • Ninio, D. M., A. M. Hill, P. R. Howe, J. D. Buckley, and D. A. Saint. 2008. Docosahexaenoic acid-rich fish oil improves heart rate variability and heart rate responses to exercise in overweight adults. British Journal of Nutrition 100:1097–103.
  • Ninio, D. M., K. J. Murphy, P. R. Howe, and D. A. Saint. 2005. Dietary fish oil protects against stretch‐induced vulnerability to atrial fibrillation in a rabbit model. Journal of Cardiovascular Electrophysiology 16:1189–94.
  • Niu, S. L., D. C. Mitchell, and B. J. Litman. 2001. Optimization of receptor-G protein coupling by bilayer lipid composition II – Formation of metarhodopsin II-transducin complex. Journal of Biological Chemistry 276:42807–11.
  • O'Keefe Jr, J. H., H. Abuissa, A. Sastre, D. M. Steinhaus, and W. S. Harris. 2006. Effects of Omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. American Journal of Cardiology 97:1127–30.
  • Oliver, E., F. C. McGillicuddy, K. A. Harford, C. M. Reynolds, C. M. Phillips, J. F. Ferguson, and H. M. Roche. 2012. Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA. Journal of Nutritional Biochemistry 23:1192–200.
  • Olsen, R.-E., R. Waagbø, W. Melle, E. Ringø, and S. P. Lall. 2011. Alternative Marine Resources. In: Fish oil Replacement and Alternative Lipid Sources in Aquaculture Feeds, G. M. Turchini, W. K. Ng and D. R. Tocher, Eds., 267–324. CRC Press, Boca Raton, FL.
  • Ostermann, A. I., and N. H. Schebb. 2017. Effects of Omega-3 Fatty Acid Supplementation on the Pattern of Oxylipins A short review about the modulation of hydroxy-, dihydroxy-, and epoxy-fatty acids. Food & Function 8:2345–622.
  • Ottestad, I., S. Hassani, G. I. Borge, A. Kohler, G. Vogt, T. Hyötyläinen, M. Orešič, K. W. Brønner, K. B. Holven, and S. M. Ulven. 2012. Fish oil supplementation alters the plasma lipidomic profile and increases long-chain PUFAs of phospholipids and triglycerides in healthy subjects. PLoS One 7:e42550.
  • Owen, A. J., B. A. Peter-Przyborowska, A. J. Hoy, and P. L. McLennan. 2004. Dietary fish oil dose-and time-response effects on cardiac phospholipid fatty acid composition. Lipids 39:955–61.
  • Park, H., J. Choi, and K. Kim. 2000. Docosahexaenoic acid-rich fish oil and pectin have a hypolipidemic effect, but pectin increases risk factor for colon cancer in rats. Nutrition Research 20:1783–94.
  • Park, Y., and W. Harris. 2002. EPA, but not DHA, decreases mean platelet volume in normal subjects. Lipids 37:941–6.
  • Patten, G. S., A. R. Bird, D. L. Topping, and M. Y. Abeywardena. 2002. Dietary fish oil alters the sensitivity of guinea pig ileum to electrically driven contractions and 8-iso-PGE(2). Nutrition Research 22:1413–26.
  • Pedersen, M. H., C. Mølgaard, L. I. Hellgren, and L. Lauritzen. 2010. Effects of fish oil supplementation on markers of the metabolic syndrome. The Journal of Pediatrics 157:395–400. e391.
  • Peoples, G. E., and P. L. McLennan. 2010. Dietary fish oil reduces skeletal muscle oxygen consumption, provides fatigue resistance and improves contractile recovery in the rat in vivo hindlimb. British Journal of Nutrition 104:1771–9.
  • Peoples, G. E., and P. L. McLennan. 2014. Long-chain n-3 DHA reduces the extent of skeletal muscle fatigue in the rat in vivo hindlimb model. British Journal of Nutrition 111:996–1003.
  • Peoples, G. E., P. L. McLennan, P. R. Howe, and H. Groeller. 2008. Fish oil reduces heart rate and oxygen consumption during exercise. Journal of Cardiovascular Pharmacology and Therapeutics 52:540–7.
  • Perluigi, M., A. M. Swomley, and D. A. Butterfield. 2014. Redox proteomics and the dynamic molecular landscape of the aging brain. Ageing Research Reviews 13:75–89.
  • Phang, M., M. L. Garg, and A. J. Sinclair. 2009. Inhibition of platelet aggregation by omega-3 polyunsaturated fatty acids is gender specific—Redefining platelet response to fish oils. Prostaglandins, Leukotrienes and Essential Fatty Acids 81:35–40.
  • Phang, M., L. Lincz, M. Seldon, and M. L. Garg. 2012a. Acute supplementation with eicosapentaenoic acid reduces platelet microparticle activity in healthy subjects. Journal of Nutritional Biochemistry 23:1128–33.
  • Phang, M., L. F. Lincz, and M. L. Garg. 2013. Eicosapentaenoic and docosahexaenoic acid supplementations reduce platelet aggregation and hemostatic markers differentially in men and women. Journal of Nutrition 143:457–63.
  • Phang, M., A. Sinclair, L. Lincz, and M. Garg. 2012b. Gender-specific inhibition of platelet aggregation following omega-3 fatty acid supplementation. Nutrition, Metabolism & Cardiovascular Diseases 22:109–14.
  • Phillips, M. A., C. E. Childs, P. C. Calder, and P. J. Rogers. 2015. No Effect of Omega-3 fatty acid supplementation on cognition and mood in individuals with cognitive impairment and probable alzheimer's disease: A randomised controlled trial. International Journal of Molecular Sciences 16:24600–13.
  • Philp, L. K., L. K. Heilbronn, A. Janovska, and G. A. Wittert. 2015. Dietary enrichment with fish oil prevents high fat-induced metabolic dysfunction in skeletal muscle in mice. PLoS One 10:e0117494.
  • Pifferi, F., M. Perret, P. Guesnet, F. Aujard, and J. M. Alessandri. 2012. Fatty acid composition of the brain, retina, liver and adipose tissue of the grey mouse lemur. Microcebus murinus, primate). Lipids 47:793–801.
  • Poppitt, S. D., C. A. Howe, F. E. Lithander, K. M. Silvers, R.-B. Lin, J. Croft, Y. Ratnasabapathy, R. A. Gibson, and C. S. Anderson. 2009. Effects of moderate-dose omega-3 fish oil on cardiovascular risk factors and mood after ischemic stroke: a randomized, controlled trial. Stroke 40:3485–92.
  • Puri, B. K., S. J. Counsell, G. Hamilton, A. J. Richardson, and D. F. Horrobin. 2001. Eicosapentaenoic acid in treatment-resistant depression associated with symptom remission, structural brain changes and reduced neuronal phospholipid turnover. International Journal of Clinical Practice 55:560–3.
  • Quinn, J. F., R. Raman, R. G. Thomas, K. Yurko-Mauro, E. B. Nelson, C. Van Dyck, J. E. Galvin, J. Emond, C. R. Jack, and M. Weiner. 2010. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 304:1903–11.
  • Rambjør, G. S., A. I. W»len, S. L. Windsor, and W. S. Harris. 1996. Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans. Lipids 31:S45–9.
  • Ramirez-Ramirez, V., M. A. Macias-Islas, G. G. Ortiz, F. Pacheco-Moises, E. D. Torres-Sanchez, T. E. Sorto-Gomez, J. A. Cruz-Ramos, G. Orozco-Avina, and A. J. C. de la Rosa. 2013. Efficacy of Fish Oil on Serum of TNF alpha, IL-1 beta, and IL-6 Oxidative Stress Markers in Multiple Sclerosis Treated with Interferon Beta-1b. Oxidative Medicine and Cellular Longevity 2013.
  • Rees, A. M., M. P. Austin, and G. B. Parker. 2008. Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial (vol 42, pg 199, 2008). Australian and New Zealand Journal of Psychiatry 42:438–438.
  • Rogers, P. J., K. M. Appleton, D. Kessler, T. J. Peters, D. Gunnell, R. C. Hayward, S. V. Heatherley, L. M. Christian, S. A. McNaughton, and A. R. Ness. 2008. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial. British Journal of Nutrition 99:421–31.
  • Ross, B. M., J. Seguin, and L. E. Sieswerda. 2007. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids in Health and Disease 6.
  • Sabour, H., B. Larijani, M. R. Vafa, M. R. Hadian, R. Heshmat, H. A. Meybodi, H. E. Razavi, A. N. Javidan, and F. Shidfar. 2012. The effects of n-3 fatty acids on inflammatory cytokines in osteoporotic spinal cord injured patients: A randomized clinical trial. Journal of Research in Medical Sciences 17:322–7.
  • Saito, M., M. Ueno, K. Kubo, and M. Yamaguchi. 1998. Dose-response effect of dietary docosahexaenoic acid on fatty acid profiles of serum and tissue lipids in rats. Journal of Agricultural and Food Chemistryb 46:184–93.
  • Santos, V. C., A. C. Levada-Pires, S. R. Alves, T. C. Pithon-Curi, R. Curi, and M. F. Cury-Boaventura. 2013. Effects of DHA-rich fish oil supplementation on lymphocyte function before and after a marathon race. International Journal of Sport Nutrition and Exercise Metabolism 23:161–9.
  • Serhan, C. N. 2005. Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins. Current Opinion in Clinical Nutrition & Metabolic Care 8:115–21.
  • Sexton, P. T., A. J. Sinclair, K. O'Dea, A. J. Sanigorski, and J. Walsh. 1995. The relationship between linoleic acid level in serum, adipose tissue and myocardium in humans. Asia Pacific Journal of Clinical Nutrition 4:314–8.
  • Silvers, K. M., C. C. Woolley, F. C. Hamilton, P. M. Watts, and R. A. Watson. 2005. Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression. Prostaglandins, Leukotrienes and Essential Fatty Acids 72:211–8.
  • Simmer, K., S. K. Patole, and S. C. Rao. 2011. Long-chain polyunsaturated fatty acid supplementation in infants born at term. The Cochrane Database of Systematic Reviews CD000376.
  • Singhal, A., J. Lanigan, C. Storry, S. Low, T. Birbara, A. Lucas, and J. Deanfield. 2013. Docosahexaenoic acid supplementation, vascular function and risk factors for cardiovascular disease: a randomized controlled trial in young adults. Journal of the American Heart Association 2:e000283.
  • Sinn, N., C. M. Milte, S. J. Street, J. D. Buckley, A. M. Coates, J. Petkov, and P. R. Howe. 2012. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial. British Journal of Nutrition 107:1682–93.
  • Sjoberg, N. J., C. M. Milte, J. D. Buckley, P. R. Howe, A. M. Coates, and D. A. Saint. 2010. Dose-dependent increases in heart rate variability and arterial compliance in overweight and obese adults with DHA-rich fish oil supplementation. British Journal of Nutrition 103:243–8.
  • Skilton, M. R., J. G. Ayer, J. A. Harmer, K. Webb, S. R. Leeder, G. B. Marks, and D. S. Celermajer. 2012. Impaired fetal growth and arterial wall thickening: a randomized trial of omega-3 supplementation. Pediatrics 129:e698–e703.
  • Skilton, M. R., T. R. Sullivan, J. G. Ayer, F. L. Garden, J. A. Harmer, S. R. Leeder, B. G. Toelle, K. Webb, G. B. Marks, and D. S. Celermajer. 2014. Weight gain in infancy is associated with carotid extra-medial thickness in later childhood. Atherosclerosis 233:370–4.
  • Slee, E. L., P. L. McLennan, A. J. Owen, and M. L. Theiss. 2010. Low dietary fish-oil threshold for myocardial membrane n-3 PUFA enrichment independent of n-6 PUFA intake in rats. Journal of Lipid Research 51:1841–8.
  • Smithers, L. G., C. T. Collins, L. A. Simmonds, R. A. Gibson, A. McPhee, and M. Makrides. 2010. Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow-up study of a randomized controlled trial. American Journal of Clinical Nutrition 91:628–34.
  • Smithers, L. G., R. A. Gibson, A. McPhee, and M. Makrides. 2008. Higher dose of docosahexaenoic acid in the neonatal period improves visual acuity of preterm infants: results of a randomized controlled trial. American Journal of Clinical Nutrition 88:1049–56.
  • Smuts, C. M., J. Greeff, J. Kvalsvig, M. B. Zimmermann, and J. Baumgartner. 2015. Long-chain n-3 PUFA supplementation decreases physical activity during class time in iron-deficient South African school children. British Journal of Nutrition 113:212–24.
  • Song, C., C. H. Shieh, Y. S. Wu, A. Kalueff, S. Gaikwad, and K. P. Su. 2016. The role of omega-3 polyunsaturated fatty acids eicosapentaenoic and docosahexaenoic acids in the treatment of major depression and Alzheimer's disease: Acting separately or synergistically? Progress in Lipid Research 62:41–54.
  • Souied, E. H., C. Delcourt, G. Querques, A. Bassols, B. Merle, A. Zourdani, T. Smith, and P. Benlian. 2013. Oral docosahexaenoic acid in the prevention of exudative age-related macular degeneration: The nutritional AMD treatment 2 study. Ophthalmology 120:1619–31.
  • Stonehouse, W., C. A. Conlon, J. Podd, S. R. Hill, A. M. Minihane, C. Haskell, and D. Kennedy. 2013. DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial. American Journal of Clinical Nutrition 97:1134–43.
  • Stough, C., L. Downey, B. Silber, J. Lloyd, C. Kure, K. Wesnes, and D. Camfield. 2012. The effects of 90-day supplementation with the Omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population. Neurobiology of Aging 33.
  • Strike, S. C., A. Carlisle, E. L. Gibson, and S. C. Dyall. 2015. A high omega-3 fatty acid multinutrient supplement benefits cognition and mobility in older women: A randomized, double-blind, placebo-controlled pilot study. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 71:236–42.
  • Sublette, M. E., S. P. Ellis, A. L. Geant, and J. J. Mann. 2011. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. The Journal of Clinical Psychiatry 72:1577–84.
  • Svennerholm, L., K. Bostrom, and B. Jungbjer. 1997. Changes in weight and compositions of major membrane components of human brain during the span of adult human life of Swedes. Acta Neuropathologica 94:345–52.
  • Teague, H., C. J. Fhaner, M. Harris, D. M. Duriancik, G. E. Reid, and S. R. Shaikh. 2013. n-3 PUFAs enhance the frequency of murine B-cell subsets and restore the impairment of antibody production to a T-independent antigen in obesity. Journal of Lipid Research 54:3130–8.
  • Teague, H., M. Harris, J. Fenton, P. Lallemand, B. M. Shewchuk, and S. R. Shaikh. 2014. Eicosapentaenoic and docosahexaenoic acid ethyl esters differentially enhance B-cell activity in murine obesity. Journal of Lipid Research 55:1420–33.
  • Thorsdottir, I., H. Tomasson, I. Gunnarsdottir, E. Gisladottir, M. Kiely, M. D. Parra, N. M. Bandarra, G. Schaafsma, and J. A. Martinez. 2007. Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content. International Journal of Obesity 31:1560–6.
  • Tihista, S., and E. Echavarria. 2017. Effect of omega 3 polyunsaturated fatty acids derived from fish oil in major burn patients: A prospective randomized controlled pilot trial. Clinical Nutrition.
  • Tokuda, H., T. Sueyasu, M. Kontani, H. Kawashima, H. Shibata, and Y. Koga. 2015. Low doses of long-chain polyunsaturated fatty acids affect cognitive function in elderly Japanese men: A randomized controlled trial. Journal of Oleo Science 64:633–44.
  • Toupchian, O., G. Sotoudeh, A. Mansoori, E. Nasli-Esfahani, M. Djalali, S. A. Keshavarz, and F. Koohdani. 2016. Effects of DHA-enriched fish oil on monocyte/macrophage activation marker sCD163, asymmetric dimethyt arginine, and insulin resistance in type 2 diabetic patients. Journal of Clinical Lipidology 10:798–807.
  • Trofimiuk, E., and J. J. Braszko. 2011. Long-Term Administration of Cod Liver Oil Ameliorates Cognitive Impairment Induced by Chronic Stress in Rats. Lipids 46:417–23.
  • Turchini, G. M., B. E. Torstensen, and W. K. Ng. 2009. Fish oil replacement in finfish nutrition. Reviews in Aquaculture 1:10–57.
  • van Goor, S. A., D. A. J. Dijck-Brouwer, B. Doornbos, J. Erwich, A. Schaafsma, F. A. J. Muskiet, and M. Hadders-Algra. 2010. Supplementation of DHA but not DHA with arachidonic acid during pregnancy and lactation influences general movement quality in 12-week-old term infants. British Journal of Nutrition 103:235–42.
  • Vedin, I., T. Cederholm, Y. F. Levi, H. Basun, A. Garlind, G. F. Irving, M. E. Joenhagen, B. Vessby, L. O. Wahlund, and J. Palmblad. 2008. Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study. American Journal of Clinical Nutrition 87:1616–22.
  • Wallace, F. A., E. A. Miles, and P. C. Calder. 2003. Comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects. British Journal of Nutrition 89:679–89.
  • Wei, M. Y., and T. A. Jacobson. 2011. Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis. Current Atherosclerosis Reports 13:474–83.
  • Weldon, S. M., A. C. Mullen, C. E. Loscher, L. A. Hurley, and H. M. Roche. 2007. Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. Journal of Nutritional Biochemistry 18:250–8.
  • Westphal, C., A. Konkel, and W.-H. Schunck. 2011. CYP-eicosanoids – a new link between omega-3 fatty acids and cardiac disease? Prostaglandins & Other Lipid Mediators 96:99–108.
  • WHO. 2017. Depression. WHO fact sheet. Available from: http://www.who.int/mediacentre/factsheets/fs369/en/.
  • Williams, J. A., S. E. Batten, M. Harris, B. D. Rockett, S. R. Shaikh, W. Stillwell, and S. R. Wassall. 2012. Docosahexaenoic and eicosapentaenoic acids segregate differently between raft and nonraft domains. Biophysical Journal 103(2):228–37.
  • Woodman, R. J., T. A. Mori, V. Burke, I. B. Puddey, A. Barden, G. F. Watts, and L. J. Beilin. 2003. Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients. Atherosclerosis 166:85–93.
  • Yagi, S., D. Fukuda, K-i. Aihara, M. Akaike, M. Shimabukuro, and M. Sata. 2017. N-3 polyunsaturated fatty acids: promising nutrients for preventing cardiovascular disease. Journal of Atherosclerosis and Thrombosis 24:999–1010.
  • Yanagisawa, A., Y. Shimojima, M. Yamagami, T. Tsujii, H. Kannda, and K. Tajino. 2002. Serum levels of long-chain saturated fatty acids positively correlate with anxiety and hostility scores in healthy young Japanese women. In S. C. Cunnane (Ed.), 5th Congress of the International Society for the Study of Fatty Acids and Lipids (ISSFAL) Montreal, 7–11 May. Abstract no. 145.
  • Yokoyama, M., H. Origasa, M. Matsuzaki, Y. Matsuzawa, Y. Saito, Y. Ishikawa, S. Oikawa, J. Sasaki, H. Hishida, and H. Itakura. 2007. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369:1090–98.
  • Yurko-Mauro, K., D. D. Alexander, and M. E. Van Elswyk. 2015. Docosahexaenoic acid and adult memory: a systematic review and meta-analysis. PLoS One 10:1–8.
  • Yurko-Mauro, K., D. McCarthy, D. Rom, E. B. Nelson, A. S. Ryan, A. Blackwell, N. Salem, M. Stedman, and M. Investigators. 2010. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimer's & Dementia 6:456–64.
  • Zhang, Y.-P., R. E. Brown, S. M. Budge, Y.-T. Zhao, X.-H. Ju, and C. Song. 2017. DHA, EPA and their combination at various ratios differently modulated Aβ 25–35-induced neurotoxicity in SH-SY5Y cells. Prostaglandins, Leukotrienes and Essential Fatty Acids.
  • Zhou, S. J., L. Yelland, A. J. McPhee, J. Quinlivan, R. A. Gibson, and M. Makrides. 2012. Fish-oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. American Journal of Clinical Nutrition 95:1378–84.